Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

TPEX:4111 Revenue

In the year 2025, Chi Sheng Pharma & Biotech had annual revenue of 1.38B TWD with 18.11% growth. Chi Sheng Pharma & Biotech had revenue of 346.98M in the quarter ending December 31, 2025, with 4.68% growth.

• Revenue: 1.38B
• Revenue Growth: +18.11%
• P/S Ratio: 1.27
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.75B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.38B	211.04M	18.11%
Dec 31, 2024	1.17B	104.57M	9.86%
Dec 31, 2023	1.06B	-82.21M	-7.19%
Dec 31, 2022	1.14B	120.78M	11.81%
Dec 31, 2021	1.02B	42.94M	4.38%